Loading interactive chart...
1DInterval:
Date Range
1 min
Advertisement
U.S. markets closed
S&P Futures
4,971.00 -78.00 (-1.54%) Dow Futures
37,507.00 -500.00 (-1.32%) Nasdaq Futures
17,219.00 -328.25 (-1.87%) Russell 2000 Futures
1,918.00 -40.10 (-2.05%) Crude Oil
85.78 +3.05 (+3.69%) Gold
2,425.20 +27.20 (+1.13%)
MedMira Inc. (47M.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Follow
At close: 08:20AM CEST
Mountain
Settings
- Simply Wall St.
MedMira Second Quarter 2024 Earnings: CA$0.001 loss per share (vs CA$0.001 loss in 2Q 2023)
MedMira ( CVE:MIR ) Second Quarter 2024 Results Key Financial Results Revenue: CA$148.7k (down 13% from 2Q 2023). Net...
- ACCESSWIRE
MedMira Reports Second Quarter Results FY2024
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 ...
- ACCESSWIRE
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
HALIFAX, NS / ACCESSWIRE / March 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of a Canadian patent patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number ...
Advertisement
Advertisement
Advertisement